A Study of Oral Ibogaine in Opioid Withdrawal
Condition:   Opiate Withdrawal Syndrome Interventions:   Drug: DMX-1002;   Drug: Placebo Sponsors:   DemeRx IB, Inc.;   MAC Clinical Research;   ERT: Clinical Trial Technology Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2021 Category: Research Source Type: clinical trials